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Quality Control by Isoleucyl-tRNA
Synthetase of Bacillus subtilis Is
Required for Efficient Sporulation
Elizabeth Kermgard1,†, Zhou Yang1, Annika-Marisa Michel1,2,*, Rachel Simari3,*,
Jacqueline Wong1,*, Michael Ibba3,4,5 & Beth A. Lazazzera1,6
Isoleucyl-tRNA synthetase (IleRS) is an aminoacyl-tRNA synthetase whose essential function is
to aminoacylate tRNAIle with isoleucine. Like some other aminoacyl-tRNA synthetases, IleRS can
mischarge tRNAIle and correct this misacylation through a separate post-transfer editing function. To
explore the biological significance of this editing function, we created a ileS(T233P) mutant of Bacillus
subtilis that allows tRNAIle mischarging while retaining wild-type Ile-tRNAIle synthesis activity. As
seen in other species defective for aminoacylation quality control, the growth rate of the ileS(T233P)
strain was not significantly different from wild-type. When the ileS(T233P) strain was assessed for its
ability to promote distinct phenotypes in response to starvation, the ileS(T233P) strain was observed
to exhibit a significant defect in formation of environmentally resistant spores. The sporulation defect
ranged from 3-fold to 30-fold and was due to a delay in activation of early sporulation genes. The loss
of aminoacylation quality control in the ileS(T233P) strain resulted in the inability to compete with a
wild-type strain under selective conditions that required sporulation. These data show that the quality
control function of IleRS is required in B. subtilis for efficient sporulation and suggests that editing
by aminoacyl-tRNA synthetases may be important for survival under starvation/nutrient limitation
conditions.
An essential step for the accuracy of mRNA translation is the charging of tRNAs with their cognate amino acid.
Aminoacyl-tRNA synthetases (aaRS) are the enzymes that catalyze this reaction, and are a family of ancient proteins that have been conserved throughout evolution, due to their essential cellular function1. AaRSs aminoacylate tRNAs through a two-step mechanism: 1) formation of an aminoacyl-adenylate (e.g. Ile-AMP by IleRS),
and 2) aminoacylation of tRNA (e.g. Ile-tRNAIle). Due to the need for accuracy in protein synthesis, some aaRSs
contain a quality control (QC) function along with their aminoacylation function2. QC functions can hydrolyze
either the aminoacyl-adenylate (pre-transfer editing) or the aminoacyl bond of charged tRNA (post-transfer editing). While aaRS editing functions are highly conserved in bacteria, archaea, and eukaryotes, QC is not essential
for cellular growth under most laboratory conditions, and few studies have identified cellular functions that rely
on aaRS editing3–7.
Isoleucine-tRNA synthetase (IleRS) possesses QC functions that discriminate between isoleucine, the
non-cognate amino acid valine, and the non-proteinogenic amino acids, norvaline, a byproduct of branched-chain
amino acid synthesis, and homocysteine (Hcy), a by-product from degradation of S-adenosylhomocysteine by
LuxS in bacteria8. The aminoacylation site of IleRS is only able to discriminate Ile from Val with an accuracy of
~1/2009. IleRS improves this accuracy with two QC activities, pre- and post-transfer editing. Pre-transfer editing
hydrolyzes Val-AMP in the synthetic site where aminoacylation also occurs10,11, and pre-transfer editing similarly hydrolyzes Hcy-AMP12. Post-transfer editing in contrast deacylates Val-tRNAIle in a domain, the connective
peptide 1 (CP1) domain, which is distinct from the site at which aminoacylation occurs13–16. Several studies have
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Figure 1. The ileS(T233P) strain mischarges tRNAIle with valine. Cell extracts of BAL4574 (WT; filled
squares) and BAL4571(ileS(T233P); open circles) were assayed for their ability to aminoacylate tRNAIle with
14
C versions of isoleucine (A), valine (B), or leucine (C). Plotted is the average pmoles of the radiolabeled tRNA
from three reactions versus the time after the addition of tRNAIle and the radiolabeled amino acid. Error bars
are standard error of the mean. Lines are best fits of the data to a Michaelis-Menton equation, with the exception
of WT in panels B and C, as the basal level of aminoacylation observed could not be fit.

identified substitutions in CP1 that disrupt post-transfer editing, but retain close to wild-type levels of aminoacylation activity13,14,17.
In vivo studies of IleRS mutants have begun to reveal potential cellular functions of QC by aaRSs. One primary
function of quality control is to prevent misincorporation in proteins of the non-cognate and non-proteinogenic
amino acids, such as valine and norvaline, respectively. Loss of IleRS QC in E. coli results in decreased growth
when the cells are grown in high concentrations of valine or norvaline18. The E. coli IleRS QC mutant strain is also
more sensitive to stressful conditions, including high temperatures and antibiotics, although the mechanism by
which these mutant cells increase their sensitivity to stress is unknown19. Loss of quality control by IleRS may also
be beneficial under certain conditions. In E. coli and Acinetobacter baylyi, loss of IleRS QC functions resulted in
an improved growth rate when concentrations of isoleucine were limiting, but moderate concentrations of valine
or norvaline were present18,20. Streptococcus pneumoniae IleRS naturally lacks a post-transfer editing function,
and mischarged tRNAIle serves as a substrate for peptidoglycan biosynthesis21. Potentially beneficial is the higher
level of mutations observed in colonies of E. coli IleRS QC-defective cells that are allowed to age; the full mechanism by which DNA mutations arise in response to loss of quality control is also unknown22. Overall, while a
number of phenotypes have been described for QC mutants, the mechanism underlying the observed changes
and their broader importance remain unknown.
To address the question of what conditions require quality control for fitness, we choose to address how loss of
QC by IleRS affects the function of the model Gram-positive organism, Bacillus subtilis. Here, we show that QC
by IleRS is required for B. subtilis, to form environmentally-resistant endospores. These endospores are formed
in response to starvation through a developmental process. This process is initiated by a master regulator, Spo0A,
and gene expression activated by this transcription factor is severely delayed in cells that lacking QC by IleRS.
Furthermore, the QC-defective IleRS strain was outcompeted by wild-type strains under conditions involving
periodic sporulation and outgrowth, supporting a general role for quality control by aaRS under starvation or
nutrient-limited conditions.

Results

Cell expressing IleRS(T233P) are defective for quality control of mischarged tRNAIle. IleRS was

chosen for this study as it has a well characterized post-transfer editing activity, and substitutions that disrupt
this editing without affecting aminoacylation have been made10,11,23. While several studies have looked at the
role of QC by IleRS in E. coli, relatively few studies have examined the importance of QC in other organisms. As
we had previously proposed that QC maybe more critical under conditions of stress that limit cellular growth3,
we chose to analyze the role of QC by IleRS in B. subtilis, which undergoes several distinct phenotypic or developmental shifts in response to starvation or slow growth, including the formation of environmentally-resistant
endospores24.
To determine the function of QC by IleRS in B. subtilis, a single point mutation was introduced into the ileS
gene on the chromosome of B. subtilis strain JH64225. The point mutation introduced causes a substitution of Thr
at codon 233 to Pro. This T233P substitution was chosen because a similar substitution in IleRS of Escherichia coli
was shown to disrupt QC by this enzyme, and while other substitutions in E. coli IleRS disrupt QC, the T233P
substitution has virtually no effect on aminoacylation activity14,23. To test whether the cells with the ileS(T233P)
allele lacked tRNAIle QC activity, cell lysates of the wild-type ileS and mutant ileS(T233P) were tested for their
ability to charge tRNAIle with either the cognate Ile or the non-cognate amino acids, Val and Leu. Lysates from
the ileS(T233P) strain showed Ile-tRNAIle production at a similar rate as lysates from wild-type cells (Fig. 1A),
indicating that the ileS(T233P) mutation did not affect the overall level of Ile-tRNAIle formation in cells. Similarly,
the ileS(T233P) lysate showed only low levels of Leu-tRNAIle production, similar to that seen with lysates from
wild-type cells, and consistent with the Leu not being an aminoacylation substrate for either wild-type IleRS or
IleRS(T233P) (Fig. 1C). Production of Val-tRNAIle however was significantly different between wild-type and
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Wild-Type
Trial

Viablea

IleRS (T233P)

Sporesb

Frequencyc

Viablea

Sporesb

Frequencyc

Difco Sporulation Media
1

5.9 ×  108

3.5 ×  108

60%

3.6 ×  108

1.3 ×  108

35%

2

6.8 ×  10

8

3.8 ×  10

56%

3.5 ×  10

8

1.2 ×  108

34%

3

4.9 ×  108

3.8 ×  108

78%

3.2 ×  108

1.6 ×  107

5%

4

4.6 ×  108

3.6 ×  108

77%

6.0 ×  108

7.1 ×  107

12%

5

3.4 ×  108

3.5 ×  108

100%

3.5 ×  108

2.5 ×  107

71%

8

Glucose Minimal Media
1

2.7 ×  108

1.8 ×  108

67%

1.6 ×  108

3.4 ×  106

2.1%

2

2.7 ×  108

2.3 ×  108

85%

1.8 ×  108

1.3 ×  107

7.2%

3

9.1 ×  107

9.2 ×  107

100%

1.1 ×  108

3.1 ×  107

27%

Table 1. Sporulation Frequency of Wild-Type and IleRS(T233P) Cells. aReported are the CFU/ml of the
cultures after 16 hours of incubation in stationary phase. bAfter testing for viable cells, the cultures were heat
treated at 80 °C for 20 minutes and then plated for CFU/ml counts. cThe frequency of sporulation was calculated
as [(spores CFU/ml)/(viable CFU/ml)*100].
ileS(T233P) cell lysates, with the ileS(T233P) lysate producing significantly more Val-tRNAIle than the wild-type
lysate (Fig. 1B). Increased Val-tRNAIle synthesis for IleRS(T233P) may either indicate improved Val recognition
and/or reduced hydrolysis of either misactivated Val-AMP or mischarged Val-tRNAIle compared with wild-type.
Importantly, whatever the precise mechanism by which the T233P substitution increased Val-tRNAIle synthesis,
this did not adversely affect the ability of cells to aminoacylate tRNAIle with its cognate amino acid and did disrupt
QC by IleRS.

Cells expressing IleRS(T233P) are defective in sporulation.

Having created a mutant strain of
B. subtilis that expresses an QC-defective version of IleRS, we sought to determine whether ileS(T233P) cells had
any phenotypic differences from wild-type. Any phenotypes altered in these mutant cells would suggest pathways
that are sensitive to QC by IleRS. The exponential growth rate (∆Ln OD600/∆time(min) ± standard deviation) in
rich medium, Difco Sporulation Medium (DSM), of wild-type cells and cells expressing IleRS(T233P) were not
significantly different (0.020 ± 0.002 and 0.021 ± 0.002, respectively). Similarly, in minimal medium, the exponential growth rate of these two strains was also not significantly different (0.011 ± 0.002 for wild-type cells and
0.010 ± 0.003 for the ileS(T233P) cells). These data are consistent with other observations of QC-defective aaRS
bacterial strains are not affected for growth under standard laboratory conditions3.
As the editing function of IleRS is conserved through evolution3, and cells in natural environments are characterized by slow growth, the wild-type and ileS(T233P) mutant B. subtilis cells were assessed for their ability to
form biofilms and spores, two major phenotypic states entered by this bacterium under slow-growth conditions26.
While wild strains of B. subtilis form more robust biofilms, laboratory strain JH642 used in this study is able
to form biofilms that adhere to the wells of a microtiter plate and to form flat, unstructured pellicle biofilms at
air-liquid interfaces27–30. Both the ileS(T233P) strain and its isogenic wild-type strain formed morphologically
indistinguishable pellicles that were observed as films of cells at the top of media in test tubes. In microtiter plates,
there was at best a small difference in how the two strains adhered to the plates, and the A570 ±  standard deviation
was 1.4 ± 0.3 for the wild-type strain and 0.87 ± 0.02 for the ileS(T233P) strain. These data support a conclusion
that the QC by IleRS is not essential for biofilm formation, although we cannot rule out a more prominent role for
editing in wild strains of B. subtilis.
To assess the ability of the ileS(T233P) mutant cells to sporulate, these cells and the isogenic wild-type control
cells were grown in DSM and incubated until sixteen hours after entry into stationary phase. At this time, the
frequency of sporulation was determined as the number of heat-resistant colony-forming units (CFU)/ml relative
to the total viable CFU/ml (Table 1). While the fold difference in the sporulation frequency of wild-type and the
ileS(T233P) cells was variable, ranging from 1.5- to 15-fold, the ileS(T233P) cells showed a statistically significant
(p = 0.015) defect in sporulation. The variability in the sporulation phenotype is not unexpected given the stochasticity in frequency of mischarging of a tRNA.
To determine whether this sporulation defect was specific to growth in DSM, cells were grown in minimal
media containing 0.1% glucose. Cells in this media exhaust glucose and transition to stationary phase at an OD600
of ~1.0. After 16 hours in stationary phase, the frequency of sporulation was assayed (Table 1). Similar to DSM
conditions, the ileS(T233P) mutant exhibited a statistically significant (p > 0.001) defect in sporulation, except
that the ileS(T233P) cells showed a larger defect in sporulation, ranging from a 4- to 30-fold defect.

The ileS(T233P) mutant is outcompeted by wild-type cells during cycles of sporulation.

To
assess the importance of the QC function of IleRS for B. subtilis, we asked how well the ileS(T233P) mutant was
able to compete with the wild-type strain. We introduced into the wild-type and ileS(T233P) strains either a
thrC::erm allele that encodes erythromycin resistance (ErmR) or a thrC::cat allele that encodes chloramphenicol
resistance (CmR). Cultures were inoculated with an equal mixture of both wild-type and ileS(T233P) cells of different antibiotic-resistance markers. In the repeats of the cultures, the antibiotic-resistance markers were swapped
between the two strains to ensure that any differences observed were due to the presence of the ileS(T233P)
mutation. The cultures were grown in DSM and passaged through a cycle of exponential growth, sporulation, and
Scientific Reports | 7:41763 | DOI: 10.1038/srep41763
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Figure 2. The ileS(T233P) strain is outcompeted by wild-type cells. Derivatives of BAL4574 (WT; circles)
and BAL4571 (ileS(T233P); squares), which carried either erythromycin-resistant or chloramphenicol-resistant
genes, were mixed in equal numbers in DSM and incubated until 16 hours post the onset of stationary phase. At
that time, the total CFU/ml (open symbols) was assessed for both cell types. The cultures were then heated to
kill vegetative cells, and the CFU/ml of spores (filled symbols) was assessed for both cell types. A 1/10th volume
of the spores was then transferred to a new DSM culture, and the process was repeated for four days. Plotted is
the average CFU/ml of four separate cultures versus the day of the competition. Error bars are standard error of
the mean.

heat-kill of non-sporulated cells. A 1/10th fraction of the spores that remained after the heat-kill step were used
to inoculate the next culture that was similarly passaged through a cycle of exponential growth, sporulation, and
heat-kill of non-sporulated cells. This was repeated for a total of four cycles. At the end of each cycle, the percent
of the spores that were from wild-type and ileS(T233P) cells was measured through CmR and ErmR CFU/ml, as
appropriate. For each independent culture started, there was a similar number of cells of each strain at the end of
the first passage, consistent with no significant differences in the growth rate of these two strains. Subsequently,
the number of ileS(T233P) cells dropped relative to the number of wild-type cells by the second or third passage, with the level of ileS(T233P) mutant after the fourth passage being 105-fold lower than wild-type (Fig. 2).
Interestingly, under these competition experiments, the ileS(T233P) mutant consistently showed a greater that
10-fold defect in sporulation (Fig. 2), unlike what was observed for this strain when grown individually (Table 1).
These data predict that the ileS(T233P) mutant would go to extinction after five cycles and strongly suggests that
sporulation is one of the evolutionary pressures maintaining the QC function of IleRS in B. subtilis.

The QC-defective IleRS mutant is defective in expressing genes activated by the master regulator
of sporulation, Spo0A. A major question from this work is why sporulation is sensitive to mistakes made by

IleRS. The process of sporulation can be divided into distinct genetic and morphological stages31. The sporulation
defect of the ileS(T233P) could stem from mistranslation of Ile codons, which could result in a non-functional
protein that is required for sporulation. If a particular protein is negatively affected in the ileS(T233P) strain, we
would predict the ileS(T233P) cells to be specifically delayed at one stage of sporulation, resulting in a strong
reduction in expression of those stage-specific genes. However, mistranslation is predicted to happen randomly
at Ile codons, with each cell having a different mixture of mistranslated proteins, and as a result each cell in a
population could be delayed at a different stage in sporulation, and we would not observe a strong effect on any
particular stage-specific gene expression at the population level.
To determine whether there is a strong decrease in stage-specific sporulation gene expression in the
ileS(T233P) mutant, we monitored gene expression of Spo0A-controlled genes. Spo0A is the first transcription
factor to become active, through phosphorylation by a phosphorelay, in the sporulation regulatory cascade32,
and if Spo0A-dependent genes have strongly reduced expression, then all subsequent stage-specific sporulation
genes will also have reduced expression. One of the operons activated by Spo0A is spoIIE, which encodes the
phosphatase required for activation of the forespore specific sigma factor, Sigma-F33. Thus, we introduced into
our isogenic wild-type and ileS(T233P) mutant a spoIIE-lacZ fusion. Cells were grown in DSM, and samples were
collected for ß-galactosidase assay at time points just prior to and for several hours after the entry into stationary
phase. As seen in Fig. 3A, while wild-type cells induced spoIIE expression one hour after entry into stationary
phase, spoIIE expression was delayed in the ileS(T233P) cells for five hours, after which point spoIIE is induced.
This late induction of spoIIE expression in the ileS(T233P) mutant may explain why sporulation does occur in the
mutant, albeit at a lower efficiency than wild-type cells.
Altered spoIIE expression in the ileS(T233P) mutant strain strongly suggests that Spo0A activity is reduced
in this mutant strain. To confirm this, we assessed expression of a second Spo0A-activated promoter, spoIIG, as
Scientific Reports | 7:41763 | DOI: 10.1038/srep41763
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Figure 3. Expression of a Spo0A-activated gene is delayed in the ileS(T233P) mutant. Strains carrying a
spoIIE-lacZ (A) or spoIIG-lacZ (B) fusion were grown in DSM. Samples were removed periodically, and the
ß-galactosidase specific activity ((ΔA420 per minute per ml of culture per OD600) × 1000) was measured and
plotted versus the time the sample was harvested relative to the time at which stationary phase for the culture
commenced. The strains grown in panel A were BAL4575 (WT; closed squares) and BAL4576 (ileS(T233P);
open circles), and strains grown in panel B were BAL4418 (WT; closed squares) and BAL4419 (ileS(T233P);
open circles). The data shown are representative of at least three independent experiments.

a lacZ fusion34. The spoIIG operon encodes the mother cell-specific sigma factor, sigma-E35. Similar to what was
seen with spoIIE expression, expression of spoIIG was defective for several hours after entry into sporulation in
the ileS(T233P) strain (Fig. 3B), confirming the general defect in Spo0A-controlled gene expression.

Discussion

Here, we present the first strain of B. subtilis to lack QC for a mischarged tRNA, specifically tRNAIle. This strain
has a point mutation in the endogenous copy of ileS, and whole cell extracts of this mutant strain mischarged
tRNAIle with valine unlike the wild-type strain. While this QC-defective strain showed no defect in exponential
growth, it has a significantly reduced ability to sporulate. The sporulation defect of the QC-defective IleRS strain
appears to be due to weak and/or delayed activation of the first transcription factor in the sporulation cascade,
Spo0A. Competition through periods of exponential growth, sporulation, and lethal challenge reveal that the
ileS(T233P) strain was rapidly outcompeted by the wild-type strain, suggesting that starvation conditions that
induce sporulation have selected for the maintenance of the IleRS QC function in B. subtilis.
The loss of QC by IleRS in B. subtilis leads to a delay in expression of sporulation genes controlled by Spo0A,
the first transcription factor that is activated in the sporulation cascade. Spo0A also regulates genes involved in
other processes including biofilm formation26, but the ileS(T233P) strain exhibited a less than two-fold defect in
the ability to form biofilms, much smaller than the defect observed for sporulation. Phosphorylation of Spo0A
is the rate-limited step for the initiation of sporulation36,37, and expression of sporulation genes requires a higher
Scientific Reports | 7:41763 | DOI: 10.1038/srep41763

5

www.nature.com/scientificreports/
level of phosphorylated Spo0A than biofilm genes38,39, suggesting that the ileS(T233P) strain may be defective in
forming high levels of phosphorylated Spo0A. Spo0A is activated by phosphorylation through a phosphorelay40,
and there are several known negative regulators of this phosphorelay. Future research will address what step along
this Spo0A activation pathway is affected in the ileS(T233P) mutant or whether there is a Spo0A-independent
mechanism that is affecting the expression of these spoII genes. Understanding how B. subtilis controls sporulation has allowed researchers to identify how cells sense cell cycle problems, which are amplified by checkpoints that delay sporulation, including DNA replication, chromosome partitioning, and tricarboycylic cycle
metabolism41,42, and research into how loss of QC by IleRS affects sporulation could reveal a novel checkpoint.
It is not known at this time if the requirement of QC for sporulation is specific to IleRS or whether loss of QC
by other aaRSs will similarly disrupt sporulation in B. subtilis. Intriguingly, the ileS gene of B. subtilis and other
endospore-forming species is adjacent to a gene, ylyA, required for spore germination43.
What causes sporulation to be so sensitive to the loss of QC by IleRS? IleRS could encounter conditions that
promote a higher rate of mischarging of tRNAIle in stationary phase, through a higher ratio of non-cognate Val
to cognate Ile. Alternatively, the rate of mischarging, and subsequent mistranslation, may be identical between
exponential growth and stationary phase, and a protein(s) involved in sporulation may be particularly sensitive
to mistranslation. A further possibility is that there is a higher ratio of charged to uncharged tRNAIle as a result
of loss of QC by IleRS, and this altered ratio may delay activation of the sporulation pathway. E. coli cells expressing an editing-defective form of the phenylalanine tRNA synthetase (PheRS), have a higher ratio of charged to
uncharged tRNAPhe under amino acid starvation and are unable to mount a stringent response44. In B. subtilis, the
stringent response is induced by uncharged tRNAs and has been shown to activate sporulation45. The higher ratio
of charged to uncharged tRNAIle in B. subtilis may also affect the putative ILE-T-Box (i.e. riboswitch) of ileS, which
could alter the levels of IleRS and possibly exacerbate the problems caused by loss of QC46,47. Biosynthesis of Ile
and other branched-chain amino acids (BCAA) is not predicted to be directly affected in the IleRS QC-defective
mutant, as aaRS are highly specific for their cognate tRNA and the BCAA biosynthesis operon ilvBHC-leuABCD
is controlled by tRNALeu and a LEU-T-Box48. Future experiments to address the potential models outlined here
for why quality control by IleRS is critical for sporulation, but not exponential growth, will require measuring cellular amino acid pools, the level of the stringent response alarmone, ppGpp, mistranslation, and charged tRNAIle
in actively growing and sporulating cells.
Sporulation by B. subtilis is a developmental process induced by starvation, specifically limitation for carbon,
nitrogen, or phosphorous49–51, and it is the major state in which B. subtilis is isolated from the environment52.
Cells lacking QC by IleRS are rapidly outcompeted by wild-type cells under conditions requiring sporulation,
which strongly argues that sporulation is the physiological condition that selects for the maintenance of QC by
IleRS in B. subtilis. These data further suggest that the primary role of QC by IleRS in other species, and possibly
QC by other aaRSs, may be in allowing survival of cells that have a severely reduced growth rate. Consistent with
this, QC by alanine tRNA synthetase (AlaRS) was shown to be required in terminally differentiated mouse neuronal cells and cardiomyocytes, non-growing or slowly-growing cell populations5,53. Intriguingly, QC by some
aaRSs has been lost from mitochondria and Mycoplasma species, many of which are intracellular parasites54–57.
This latter finding suggests that, in the absence of changing environmental conditions, QC by aaRSs may not be
required and is consistent with the suggestion of the work presented here that QC is required by cells that must
transition from rapid growth to slow-growth/stationary phase induced by nutrient limitation.
In summary, we have shown for the first time that the quality control function of a tRNA synthetase is critical
for sporulation in B. subtilis. The IleRS QC was required for activating the genes controlled by the master transcription factor, Spo0A, and cells lacking IleRS QC were rapidly lost from a mixed population when a selection
for sporulation was applied. These data suggest that the QC function of tRNA synthetases may be conserved to
deal with particular stress conditions that are encountered by cells as their growth slows or they enter stationary
phase in response to nutrient limitation.

Experimental Procedures.

ously described58.

tRNA Preparation.

Bacillus subtilis tRNAIle was transcribed in vitro as previ-

Cell Free Extract Preparation. B. subtilis tRNA-free cell free extracts were prepared as described59, using strains
containing either a wild-type ileS gene or an editing deficient allele of ileS (ileS(T233P)), except EDTA-free protease inhibitor (Roche) was used during lysis to replace PMSF. Briefly, the supernatant following ultracentrifugation was loaded onto DEAE Sephacel (GE) resin. Cell free extracts were quantified using a BCA Protein Assay kit
(Thermo Scientific Pierce).
Aminoacylation Assays. Aminoacylation assays using cell free extracts of wild-type ileS and ileS(T233P) strains
were performed as previously described21. Each reaction contained 450 μg extract protein, 1070 ng/μL of B. subtilis tRNAIle, 0.1 mM cognate [14C]Ile at 200 cpm/pmol (Moravek Biochemicals), 0.15 mM non-cognate [14C]Val
at 120 cpm/pmol (PerkinElmer), and 0.3 mM non-cognate [14C]Leu at 120 cpm/pmol (Moravek Biochemicals).
Growth conditions. E. coli and B. subtilis strains were routinely grown in Luria-Bertani (LB) medium. For sporulation assays, B. subtilis strains were grown in either Difco sporulation medium (DSM)60 or S750 minimal medium
with 0.1% glucose61. Both E. coli and B. subtilis strains were grown at 37 °C. Antibiotics were used as required
at the following concentrations: ampicillin 100 μg/ml, chloramphenicol 5 μg/ml, erythromycin 0.5 μg/ml, and
tetracycline 12.5 μg/ml. The growth rate was measured as the slope of the line from the natural log of the OD600
readings versus the time of incubation in minutes. Only points in exponential growth were used for a line fit, and
only line fits that gave an R-value greater than 0.99 were considered valid.
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Strain construction. E. coli strain Top10 (Invitrogen) was used for the routine construction and maintenance of
plasmids. The B. subtilis strains used in this study are all derivatives of the JH642 strain, which contains the trpC2
and pheA1 mutations25 and were constructed by transformation of genetically competent cells with chromosomal
DNA or plasmids using standard protocols60. Gene replacement was verified using PCR.
The B. subtilis ileS(T233P) strain was constructed by transformation with a plasmid, pBL4566, containing
the ileS(T233P) gene. The pBL4566 plasmid is a derivative of pJet1.2 (Thermo Fisher) that contains a restriction site for the I-SceI meganuclease62 and the cat gene for chloramphenicol resistance. The ileS gene was PCR
amplified with primers ileS-F (5′-GCATGGATCCAAGGAATAAATTCTCTGATTA) and ileS-R (5′- GCA
TAGATCTGCATATCGGTCAACTGAACGC) and ligated to pJet1.2 according to the instructions of the CloneJET
PCR Cloning Kit (ThermoFisher Scientific). An I-SceI-cat cassette was constructed by PCR amplification with
pJH10163 as a template and primers I-SceI-cat-A (5′-ATGCCT GCAGT
 AGGGATAACAGGGTAATTAT T
G GG CG CT CT TC CG CTA AG CATGCGTTACCCTTATTATCAAGA) and I-SecI-cat-B (5′ - ATGC
CTGCAGGCGAGTCAGTGAGCGAGGAAGCAAGCATGCGGAGCTGTAATATAAAAAC), in which the
underlined sequence corresponds to the cat gene, the I-SecI site is bold, and PstI restriction sites are italicized.
Both the I-SceI-cat PCR and the pJet1.2-ileS plasmid were digested with PstI and ligated, to yield a
pJet-ileS-I-SceI-cat plasmid. This plasmid was subjected to site-directed mutagenesis using primers T233P-F
(5′- GCATCATCATTTGGACACCAACGCCGTGGACAATT) and its reverse complement (the bold, underlined nucleotide is the introduced mutation), according to directions of Quikchange Lightning Site-Directed
Mutagenesis Kit (Agilent Technologies). The presence of the mutation was confirmed by DNA sequencing, and
the resulting plasmid was named pBL4566.
To transfer the ileS(T233P) allele on pBL4566 to the chromosome of B. subtilis, a wild-type strain of B. subtilis,
JH64225, was transformed with pBL4566, and transformants were selected on plates containing chloramphenicol.
The resulting strain, BL4568, which has pBL4566 integrated into its chromosome at the ileS locus, has two alleles
of ileS, one wild-type and one ileS(T233P), flanking the pJet1.2 plasmid backbone and the I-Sce1-cat cassette.
To return the chromosome to just one copy of ileS and remove the pBL4566 plasmid, the pBKJ223 plasmid that
expresses the I-Sce1 meganuclease64 was transformed into BAL4568, and transformants were selected on plates
containing tetracycline. I-Sce1 cleaves the chromosome at the I-SceI restriction site on the pBL4566 plasmid,
and repair of this DNA break by homologous recombination results in a strain that has removed the plasmid
sequences and restored the native ileS chromosomal structure, with the ileS allele present being either wild-type
or ileS(T233P). To screen for cells that have lost the plasmid sequence, transformants were screened for chloramphenicol sensitivity. The ileS allele present in the chloramphenicol-sensitive clones were screened by PCR
amplification and DNA sequencing, including the genes to either side of ileS, ylyA and divIVA. One strain with
the ileS(T233P) allele and one with the wild-type ileS allele were selected. To remove pBKJ223 from the desired
clones, cells were grown in LB liquid cultures lacking antibiotic selection. Colonies from these cultures were
streak-purified on LB agar plates and then screened for tetracycline sensitivity. Two tetracycline-sensitive clones,
one wild-type ileS and one ileS(T233P), were named BAL4574 and BAL4571, respectively. To assay expression
of sporulation genes, thrC::(spoIIE-lacZ, erm)65,66 and Spß::(spoIIG-lacZ, cat)67 were introduced into BAL4574
(wild-type) and BAL4571 (ileS(T233P)).
Sporulation Assays. To assess the ileS(T233P) mutant for sporulation, strains were assessed for the presence of
heat-resistant spores, as previously described60. Briefly, cells were grown in liquid Difco Sporulation Medium
(DSM) until 16 hours after the onset of stationary phase. At this time, the total viable CFU/ml was measured and
then the cultures were heated at 80 °C for 20 minutes, and the heat-resistant CFU/ml was measured as the number
of spores present.
β-Galactosidase Assays. Cells were grown as described above for sporulation assays, except that samples were
harvested throughout the exponential growth phase and several hours past the entry of the cultures into stationary phase. The cells were then harvested by centrifugation, and resuspended in Z-Buffer, and ß-galactosidase
activity was measured as previously described68. β-galactosidase-specific activity is presented as (ΔA420 per minute per ml of culture per OD600) ×  1000).
Biofilm formation Assays. Cells were grown for 24 hours in polyvinyl chloride microtiter plates in Biofilm
Growth Medium, a modified LB based medium supplemented with 124 mM potassium phosphate pH 7.0, 15 mM
ammonium sulphate, 3.4 mM sodium citrate, 0.01 mM MgSO4, and 0.1% glucose as previously described28–30.
After incubation, the wells were washed twice and subsequently stained with crystal violet. The wells were rinsed
to remove any non-adherent crystal violet and treated with a solubilizing solution of 80% ethanol, 20% acetic
acid; the A570 of the solution was then measured. The A570 of 16–24 wells were averaged. When the SEM (standard
error of the mean) of the A570 measurements obtained for the 16–24 wells was <10% of the mean, the assay was
considered valid. Each assay was repeated on at least three independent occasions, and the averages from all valid
assays were averaged to determine the level of biofilm formation for a strain.
Growth of pellicle biofilms. Bacterial cells were inoculated at OD600 0.025 into Biofilm Growth Medium and
grown with shaking until OD600 ~1.0. The cells were diluted into fresh Biofilm Growth Medium to an OD600 of
0.01 and 5 ml were added to culture test tubes. The tubes were incubated at 37 °C for 48 hours with no shaking, at
which times the pellicles were imaged.
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